Doxazosin
- Product NDC
- 68071-3341
- 11-digit product format
- 680713341
- Labeler code
- 68071
- Product ID
- 68071-3341_4af89eb5-31fa-09ac-e063-6294a90af454
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA075580
- Marketing category
- ANDA
- Marketing start
- 2011-07-14
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197626 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3341-3 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
| 68071-3341-6 | Doxazosin | 60 in 1 BOTTLE | TABLET | 60 | | 4 |
| 68071-3341-9 | Doxazosin | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68071-3341-3 | 68071334103 | 30 TABLET in 1 BOTTLE (68071-3341-3) | 30 tablet | 2017-07-11 | No | No | Historical |
| 68071-3341-6 | 68071334106 | 60 TABLET in 1 BOTTLE (68071-3341-6) | 60 tablet | 2017-07-11 | No | No | Historical |
| 68071-3341-9 | 68071334109 | 90 TABLET in 1 BOTTLE (68071-3341-9) | 90 tablet | 2017-07-11 | No | No | Historical |